Digital-asset treasury stocks have become a distinct category for traders seeking equity exposure to cryptocurrency price movements. ASST and CYPH both belong to this emerging group, yet they differ sharply in the assets they hold and the businesses attached to their balance sheets. This stock comparison examines their relative performance, market positioning, and risk profiles for investors and traders evaluating which name offers a more compelling risk-reward setup in the current environment. Because both equities move with the volatile crypto market, this comparison is most relevant to active traders and investors comfortable with elevated price swings rather than those seeking steady, income-oriented holdings.
ASST, formally Asset Entities Inc., now operates as Strive, Inc. following a 2025 reverse merger that repositioned the company as a Bitcoin treasury vehicle. The company has steadily accumulated Bitcoin on its balance sheet, holding a reserve measured in the tens of thousands of coins in recent periods, and has used perpetual preferred stock offerings to fund additional purchases. In recent weeks, the firm reported a substantial GAAP (Generally Accepted Accounting Principles) net income figure driven primarily by unrealized gains on its Bitcoin holdings, even as operating revenue remained small. This reliance on mark-to-market accounting means headline profits can swing dramatically with Bitcoin prices. Sell-side analysts have issued Buy ratings with price targets well above recent trading levels, reflecting confidence in the treasury strategy, though the stock remains highly volatile and sensitive to digital-asset sentiment.
CYPH, Cypherpunk Technologies Inc., is a privacy-technology company whose digital-asset strategy is anchored to Zcash (ZEC), a privacy-focused cryptocurrency. The company is among the largest corporate holders of ZEC and, in recent months, launched a Zcash mining fleet that adds operational cash flow to its treasury accumulation model. Like ASST, it reported a large quarterly net profit driven by unrealized gains after Zcash rallied, only for the token to retrace afterward—illustrating how quickly reported results can reverse. A legacy biotechnology segment adds an additional, largely unrelated risk and opportunity layer. CYPH has delivered a triple-digit one-year return but remains extremely volatile, with a wide gap between its 52-week high and low and substantial single-session swings.
Tickeron operates hundreds of AI trading bots that collectively monitor and trade thousands of different tickers across varying styles, strategies, timeframes, and risk profiles. Rather than listing every system, Tickeron curates a focused selection of the best-performing and most suitable bots for current market conditions on its Trending AI Robots page. These featured bots are backed by trackable statistics, including historical performance, win rates, and trade frequency, giving users a way to evaluate automated strategies before committing capital. Each bot follows its own methodology and set of tickers, so no single approach fits every market regime. For traders seeking a data-driven way to filter opportunity across the equity universe, the Trending AI Robots page offers a practical starting point.
The core contrast between ASST and CYPH lies in the liquidity and breadth of their underlying assets. Bitcoin, backing ASST, enjoys deeper institutional adoption and a larger, more established market than Zcash, which underpins CYPH. This gives ASST a comparatively more liquid foundation, though both names remain far more volatile than the broader market. On growth drivers, CYPH offers diversification through mining cash flow and a biotech pipeline, while ASST offers a purer, larger-scale exposure to Bitcoin with more active sell-side coverage. On risk, both carry concentrated single-asset exposure, share-dilution from equity-linked financing, and earnings that can swing from large gains to losses as token prices move. Sector exposure also differs: ASST skews toward financial-services and digital-asset custody themes, while CYPH blends crypto mining, privacy technology, and healthcare.
Based on observable factors rather than predictions, Tickeron's AI currently tilts toward ASST as the more favorable of the two. The rationale centers on the relative liquidity of its underlying asset, its larger treasury footprint, broader analyst coverage, and the presence of clear, recurring catalysts through its preferred-stock financing programs. CYPH presents meaningful upside potential and genuine operational diversification, but its smaller, more niche underlying token and a mixed business mix introduce comparatively higher inconsistency in trend and sentiment. Both stocks carry elevated risk, and neither offers the stability of a conventional large-cap equity, so this verdict reflects a probabilistic lean rather than a definitive outcome.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ASST moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend. In 27 of 30 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ASST as a result. In 55 of 63 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The 10-day moving average for ASST crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ASST entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +8.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASST advanced for three days, in 142 of 163 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
ASST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. ASST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.242) is normal, around the industry mean (2.423). P/E Ratio (-28.942) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.318). Dividend Yield (0.000) settles around the average of (0.274) among similar stocks. ASST's P/S Ratio (113.636) is very high in comparison to the industry average of (15.906).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
CYPH saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 30, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 37 instances where the indicator turned negative. In 34 of the 37 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CYPH as a result. In 67 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
CYPH moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CYPH crossed bearishly below the 50-day moving average on November 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CYPH entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for CYPH's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +21.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYPH advanced for three days, in 216 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. CYPH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.228) is normal, around the industry mean (2.423). P/E Ratio (4.500) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.318). Dividend Yield (0.000) settles around the average of (0.274) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (15.906).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
CYPH | ||
|---|---|---|
OUTLOOK RATING 1..100 | 69 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 91 | |
PRICE GROWTH RATING 1..100 | 60 | |
P/E GROWTH RATING 1..100 | 92 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ASST | CYPH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 87% | 2 days ago 89% |
| MACD ODDS (%) | N/A | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 89% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 89% |
| Advances ODDS (%) | 11 days ago 87% | 18 days ago 89% |
| Declines ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | N/A |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASST’s FA Score shows that 0 FA rating(s) are green while CYPH’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASST’s TA Score shows that 4 TA indicator(s) are bullish while CYPH’s TA Score has 3 bullish TA indicator(s).
ASST (@Investment Managers) experienced а -32.07% price change this week, while CYPH (@Investment Managers) price change was -24.60% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was -8.27%. For the same industry, the average monthly price growth was -9.09%, and the average quarterly price growth was -10.90%.
Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
A.I.dvisor indicates that over the last year, ASST has been closely correlated with DFDV. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if ASST jumps, then DFDV could also see price increases.
| Ticker / NAME | Correlation To ASST | 1D Price Change % | ||
|---|---|---|---|---|
| ASST | 100% | -12.64% | ||
| DFDV - ASST | 71% Closely correlated | -15.29% | ||
| FWDI - ASST | 67% Closely correlated | -16.75% | ||
| HSDT - ASST | 60% Loosely correlated | -10.24% | ||
| STKE - ASST | 54% Loosely correlated | -6.48% | ||
| SATA - ASST | 49% Loosely correlated | -3.75% | ||
More | ||||
A.I.dvisor indicates that over the last year, CYPH has been loosely correlated with FWDI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CYPH jumps, then FWDI could also see price increases.
| Ticker / NAME | Correlation To CYPH | 1D Price Change % | ||
|---|---|---|---|---|
| CYPH | 100% | -18.02% | ||
| FWDI - CYPH | 53% Loosely correlated | -16.75% | ||
| DFDV - CYPH | 52% Loosely correlated | -15.29% | ||
| ASST - CYPH | 47% Loosely correlated | -12.64% | ||
| HSDT - CYPH | 43% Loosely correlated | -10.24% | ||
| INKT - CYPH | 42% Loosely correlated | -7.42% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BTCZ | 5.70 | 0.60 | +11.76% |
| T-Rex 2X Inverse Bitcoin Daily Target ETF | |||
| KTN | 25.83 | 0.03 | +0.10% |
| Structured Products CorTS Aon Capital A | |||
| NMS | 9.87 | -0.03 | -0.30% |
| Nuveen Minnesota Quality Municipal Income Fund | |||
| PY | 55.98 | -0.88 | -1.55% |
| Principal Value ETF (PY) | |||
| STK | 42.66 | -3.58 | -7.74% |
| Columbia Seligman Premium Technology Growth Fund | |||